Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.4200 (-0.93%) ($6.3600 - $6.4900) on Tue. Jul. 19, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.05% (three month average) | RSI | 47 | Latest Price | $6.4200(-0.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.9% a day on average for past five trading days. | Weekly Trend | CGEN declines -0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IPO(6%) EWG(5%) URA(5%) XRT(4%) EWI(3%) | Factors Impacting CGEN price | CGEN will decline at least -1.025% in a week (0% probabilities). VCIT(-8%) VCSH(-7%) TIP(-7%) BWX(-7%) BNDX(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.025% (StdDev 2.05%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $6.63 | 5 Day Moving Average | $6.51(-1.38%) | 10 Day Moving Average | $6.61(-2.87%) | 20 Day Moving Average | $6.63(-3.17%) | To recent high | -9.8% | To recent low | 1.9% | Market Cap | $531m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |